KBG Corp, formerly Korea Bio-Gen Co Ltd, is a Korea-based company mainly engaged in silicone materials business. The Company manufactures and sells silicone materials such as silane monomers, silicone resins and polymers, and silicone fusion materials. The Company also produces and sell fine chemicals and bio products.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
10/07/26	₩3,080.00	+2.33%	6,120
09/07/26	₩3,010.00	+0.67%	8,431
08/07/26	₩2,990.00	-0.99%	20,026
07/07/26	₩3,020.00	-3.36%	14,833
06/07/26	₩3,125.00	+2.12%	5,186

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. Other stock markets 10/07/2026			5-day change	1st Jan Change
3,080.00 ^KRW	+2.33%		+0.65%	-30.00%

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
10/07/24	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI

Market Cap	26.79B 17.84M 15.61M 14.4M 13.3M 25.23M 1.7B 25.65M 172M 67.55M 838M 67M 65.54M 2.88B	P/E 2024	10.8x	P/E 2025	14.8x
Enterprise Value	10.06B 6.7M 5.86M 5.4M 4.99M 9.47M 639M 9.63M 64.55M 25.35M 315M 25.14M 24.6M 1.08B	EV / Sales 2024	1.22x	EV / Sales 2025	0.9x
Free-Float	63.58%	Yield 2024 *	-	Yield 2025	-

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
10/07/24	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI
27/06/24	KBG Corp. agreed to acquire Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD for KRW 8.3 billion.	CI
12/05/23	KBG Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
11/05/21	Korea Bio-Gen Co.,Ltd announced that it has received KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
09/05/21	Korea Bio-Gen Co.,Ltd announced that it expects to receive KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
16/09/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
16/09/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
15/09/20	Korea Bio-Gen Co.,Ltd's Equity Buyback announced on March 17, 2020, has expired with 79,364 shares, representing 0.98% for KRW 318.89 million.	CI
17/06/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
17/03/20	Korea Bio-Gen Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	CI
16/03/20	Korea Bio-Gen Co.,Ltd authorizes a Buyback Plan.	CI
30/07/19	Korea Bio-Gen Co.,Ltd has completed an IPO in the amount of KRW 10.707 billion.	CI

1 day	+2.33%
1 week	+0.65%
Current month	+6.39%
1 month	-3.75%
3 months	-27.27%
6 months	-28.87%
Current year	-30.00%

KBG Corp. Share Price

Stocks

A318000

KR7318000007

Specialty Chemicals

Valuation: KBG Corp.

Chart: KBG Corp.

Latest news : KBG Corp.

Quotes and Performance

Course Extremes

Managers and Directors: KBG Corp.

Other Specialty Chemicals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	2,900	3,145
1 month	2,810	3,530
Current year	2,810	4,830
1 year	2,810	6,340
3 years	2,810	14,340
5 years	2,810	21,150
10 years	2,810	21,150

Manager	Title	Age	Since
Sam-Yeol Pu CEO	Chief Executive Officer	40	23/03/2022
Tae-Kyun Boo SAM	Sales & Marketing	60	29/02/2020
Sang-Ho Do AUD	Comptroller/Controller/Auditor	67	-

Director	Title	Age	Since
Tae-Ung Pu CHM	Chairman	68	-
Sam-Yeol Pu BRD	Director/Board Member	40	23/03/2022
Kyung Choi BRD	Director/Board Member	68	24/03/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KBG CORP.	+2.33%	+0.65%	-32.16%	-72.98%	17.84M
ECOLAB INC.	+0.47%	-3.19%	+2.82%	+49.33%	77.2B
GIVAUDAN SA	+0.41%	-2.11%	-11.02%	+17.33%	39.27B
SIKA AG	+0.99%	-6.81%	-22.94%	-33.87%	32.36B
FUJIFILM HOLDINGS CORPORATION	+0.73%	-0.97%	+19.73%	+30.07%	26.33B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-1.21%	+0.67%	+87.09%	-7.79%	20.91B
EMS-CHEMIE HOLDING AG	+4.24%	+2.22%	+14.71%	+5.78%	20.68B
DUPONT DE NEMOURS, INC.	-0.08%	-3.74%	-41.03%	-36.16%	18.18B
ALBEMARLE CORPORATION	-1.85%	-7.02%	+69.72%	-47.45%	14.87B
SYMRISE AG	+0.07%	-3.02%	-2.64%	-5.18%	13.94B
Average	+0.61%	-2.42%	+8.43%	-10.09%	26.38B
Weighted average by Cap.	+0.52%	-2.67%	+7.36%	+10.26%

	2024	2025
Net sales	24.92B 16.59M 14.51M 13.39M 12.36M 23.46M 1.58B 23.86M 160M 62.81M 780M 62.3M 60.94M 2.68B	23.92B 15.93M 13.93M 12.85M 11.87M 22.52M 1.52B 22.9M 154M 60.31M 748M 59.81M 58.51M 2.57B
Net income	3.77B 2.51M 2.19M 2.02M 1.87M 3.55M 239M 3.61M 24.18M 9.5M 118M 9.42M 9.21M 405M	2.59B 1.73M 1.51M 1.39M 1.29M 2.44M 165M 2.48M 16.64M 6.53M 81.1M 6.48M 6.34M 279M
Net Debt	-10.55B -7.03M -6.15M -5.67M -5.24M -9.94M -670M -10.11M -67.76M -26.61M -330M -26.39M -25.82M -1.14B	-16.74B -11.15M -9.75M -8.99M -8.31M -15.76M -1.06B -16.03M -107M -42.2M -524M -41.85M -40.94M -1.8B